The Bone Marrow Microenvironment in Waldenstrom Macroglobulinemia

被引:9
|
作者
Agarwal, Amit [1 ]
Ghobrial, Irene M. [2 ]
机构
[1] Univ Arizona, Div Hematol Oncol, Tucson, AZ USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2013年 / 13卷 / 02期
关键词
TUMOR MICROENVIRONMENT; SOMATIC MUTATION; CELL-GROWTH; ABNORMALITY; CYTOKINES; SUGGESTS; THERAPY; MYELOMA;
D O I
10.1016/j.clml.2013.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma characterized by widespread involvement of the bone marrow (BM). The BM microenvironment serves as not only a site for disease involvement, but it also appears that the interaction of WM cells with the BM is essential for the pathogenesis of WM. The BM microenvironment consists of the cellular and noncellular compartments. The BM has been shown to regulate cell proliferation, cell cycle, and drug resistance as well as cell dissemination and cell trafficking of WM cells. A better understanding of the role of the BM microenvironment in the pathogenesis of WM can help guide better therapeutic strategies that can target the tumor clone and also regulate the BM microenvironment.
引用
下载
收藏
页码:218 / 221
页数:4
相关论文
共 50 条
  • [1] The Bone Marrow Microenvironment in Waldenstrom Macroglobulinemia
    Jalali, Shahrzad
    Ansell, Stephen M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (05) : 777 - +
  • [2] The bone marrow microenvironment in Waldenstrom macroglobulinemia
    Ghobrial, Irene M.
    Maiso, Patricia
    Azab, Abdelkareem
    Liu, Yang
    Zhang, Yong
    Issa, Ghayas
    Azab, Feda
    Sacco, Antonio
    Quang, Phong
    Hai Ngo
    Roccaro, Aldo
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (04) : 267 - 272
  • [3] Bone marrow microenvironment in Waldenstrom's Macroglobulinemia
    Jalali, Shahrzad
    Ansell, Stephen M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2016, 29 (02) : 148 - 155
  • [4] The Bone Marrow Niche in Waldenstrom's Macroglobulinemia
    Ghobrial, Irene M.
    Zhang, Yong
    Liu, Yang
    Hai Ngo
    Azab, Feda
    Sacco, Antonio
    Azab, Abdelkareem
    Maiso, Patricia
    Morgan, Brittany
    Phong Quang
    Issa, Ghayas
    Roccaro, Aldo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01): : 118 - 120
  • [5] Assessment of Bone Marrow Response in Waldenstrom's Macroglobulinemia
    Varghese, Abraham M.
    Rawstron, Andy C.
    Ashcroft, A. John
    Moreton, Paul
    Owen, Roger G.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (01): : 53 - 55
  • [6] Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia
    Martino, R
    Shah, A
    Romero, P
    Brunet, S
    Sierra, J
    Domingo-Albós, A
    Fruchtman, S
    Isola, L
    BONE MARROW TRANSPLANTATION, 1999, 23 (07) : 747 - 749
  • [7] Allogeneic bone marrow transplantation for advanced Waldenstrom’s macroglobulinemia
    R Martino
    A Shah
    P Romero
    S Brunet
    J Sierra
    A Domingo-Albós
    S Fruchtman
    L Isola
    Bone Marrow Transplantation, 1999, 23 : 747 - 749
  • [8] IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia
    Hodge, Lucy S.
    Ziesmer, Steve C.
    Yang, Zhi Zhang
    Secreto, Frank J.
    Gertz, Morie A.
    Novak, Anne J.
    Ansell, Stephen M.
    BLOOD, 2012, 120 (18) : 3774 - 3782
  • [9] Cytokines in the Microenvironment of Waldenstrom's Macroglobulinemia
    Elsawa, Sherine F.
    Ansell, Stephen M.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (01): : 43 - 45
  • [10] Clinical , Laboratory, and Bone Marrow Findings of 31 Patients With Waldenstrom Macroglobulinemia
    Ahn, Ari
    Park, Chan-Jeoung
    Cho, Young-Uk
    Jang, Seongsoo
    Seo, Eul-Ju
    Lee, Jung-Hee
    Yoon, Dok Hyun
    Suh, Cheolwon
    ANNALS OF LABORATORY MEDICINE, 2020, 40 (03) : 193 - 200